D-Lab — Anti-Sugar Detox

This formula presents a clinically coherent association logic on the glucose-liver axis. AMYRASE® (Phaseolus vulgaris phaseolamine) is the best-documented active ingredient: its inhibitory mechanism on pancreatic alpha-amylase is established in the literature, with studies showing a reduction in postprandial glycemic response to starches. Gymnema sylvestre (gymnemates) and Ceylon cinnamon have traditional use data and some clinical studies on glucose tolerance, but no authorized EU claims. Milk thistle (silymarin 42.4 mg) is the only active ingredient targeting the liver—relevant because the liver is central to endogenous glucose regulation. Chromium at 40 µg benefits from the authorized EU claim for normal blood glucose, but the dose is modest. Pharmacist vigilance points: the risk of hypoglycemia in combination with antidiabetic treatments is the most important contraindication for this product, not sufficiently highlighted in the manufacturer's communication. Milk thistle inhibits CYP3A4 and CYP2C9, which can affect the metabolism of many drugs (coumarin anticoagulants, certain statins, cyclosporine)—information missing from the product sheet. This supplement is part of the CLEAR and GLOW packs via the skin glycation axis, a documented mechanism by which excess glucose degrades dermal collagen and elastin. Paradermia's communication remains focused on skin glycation and glycemic comfort, not weight loss.